Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human CALCRL Antibodies:
anti-Mouse (Murine) CALCRL Antibodies:
anti-Rat (Rattus) CALCRL Antibodies:
Go to our pre-filtered search.
Chicken Polyclonal CALCRL Primary Antibody for WB - ABIN2775326
Eskesen, János, Tibor, Délia, László, Edvinsson: Unaltered mRNA expression of calcitonin-like receptor and receptor activity modifying proteins in human arteries in stroke and myocardial infarction. in Ideggyógyászati szemle 2008
Human Polyclonal CALCRL Primary Antibody for IHC, IHC (p) - ABIN4287076
Arimappamagan, Somasundaram, Thennarasu, Peddagangannagari, Srinivasan, Shailaja, Samuel, Patric, Shukla, Thota, Prasanna, Pandey, Balasubramaniam, Santosh, Chandramouli, Hegde, Kondaiah et al.: A fourteen gene GBM prognostic signature identifies association of immune response pathway and mesenchymal subtype with high risk group. ... in PLoS ONE 2013
interaction of RAMP2 (show RAMP2 Antibodies) or RAMP3 (show RAMP3 Antibodies) with CLR (show DCLK3 Antibodies) induces conformational variation in the juxtamembrane region, yielding distinct binding pockets, probably via an allosteric mechanism.
STC1 (show STC1 Antibodies) interferes with CALCRL signaling during osteoblastogenesis via adenylate cyclase inhibition.
Data suggest that ligand binding of a G protein-coupled receptor (GPCR (show TAS1R3 Antibodies)) may inform drug development targeting calcitonin receptor-like receptor (CLR):receptor activity-modifying proteins RAMP1 (show RAMP1 Antibodies)/2 complexes.
the AM system is widely expressed in human thymus from newborns; both AM1 receptor components CLR (show DCLK3 Antibodies) and RAMP2 (show RAMP2 Antibodies), but not RAMP3 (show RAMP3 Antibodies), are not associated with the plasma membrane of TECs and thymocytes but are located intracellularly, notably in the nucleus
Two CALCRL variants were associated with risk for gestational diabetes.
Data suggest isoforms of RAMP (receptor activity-modifying protein) modulate accessibility of peptides to residues situated on CALCRL N-terminal domain; RAMP3 (show RAMP3 Antibodies)/RAMP2 (show RAMP2 Antibodies)/RAMP1 (show RAMP1 Antibodies) appear to alter accessibility of specific residues at CALCRL-RAMP interface.
CRLR expression is upregulated in the fetal lung with increasing gestational age.
The G-protein-coupled receptor (show ADRA1A Antibodies) CLR (show DCLK3 Antibodies) is upregulated in an autocrine loop with adrenomedullin (show ADM Antibodies) in clear cell renal cell carcinoma (show MOK Antibodies) and associated with poor prognosis.
An alanine scan of residues 271-294 of CLR (show DCLK3 Antibodies) showed that the ability of CGRP (show S100A12 Antibodies) to produce cAMP was impaired by point mutations at 13 residues; most of these also impaired the response to adrenomedullin (show ADM Antibodies) (AM).
The study implicates genetic variation at the CALCRL gene in the pathogenesis of primary angle closure glaucoma in an Australian Caucasian cohort.
these data indicate that the structural integrity of caveolae plays an important role in regulating subcellular distribution of CLR (show CALCR Antibodies).
Calcrl deficiency results in multi-organ lymphangiectasia in adult mice.
Data show that mechanical ventilation reduced the expression of receptor activity-modifying protein RAMP3 (show RAMP3 Antibodies), but not of intermedin (IMD (show ADM2 Antibodies)), calcitonin receptor-like receptor (CRLR), and RAMP1 (show RAMP1 Antibodies) and RAMP2 (show RAMP2 Antibodies).
role in cell surface expression of CRLR/RAMP heterodimeric receptors
The Calcrl gene targeted mice provide the first in vivo genetic evidence that Calcitonin receptor (show CALCR Antibodies) functions as an Adrenomedullin receptor (show GPR182 Antibodies) during embryonic development.
loss of calcrl in endothelial cells confirmed an essential role for AM signaling in vascular development.
CTR (show CALCR Antibodies) is not only down regulated by signaling through the CTR (show CALCR Antibodies) but also by the peptides signaling through calcitonin receptor-like receptor, and receptor activity modifying proteins
Data suggest that ADM (adrenomedullin (show ADM Antibodies)) increases oviductal fluid secretion via chloride secretion by calcium and cAMP signal pathways (not nitric oxide signal pathway) via CGRPR (calcitonin gene-related peptide (show CALCA Antibodies) receptor; not adrenomedullin receptor (show GPR182 Antibodies)).
Data indicate that adrenomedullin (show ADM Antibodies) mRNA and protein signal were only found in trophoblast binucleate cells (BNCs), whereas those of CRLR, RAMP2 (show RAMP2 Antibodies) and RAMP3 (show RAMP3 Antibodies) were detected in cotyledonary villous and caruncular epithelial cells.
Receptor for calcitonin-gene-related peptide (CGRP) (By similarity). Receptor specificity may be modulated by accessory proteins. The activity of this receptor is mediated by G proteins which activate adenylyl cyclase (By similarity).
, calcitonin gene-related peptide type 1 receptor-like
, CGRP type 1 receptor
, Calcitonin receptor-like receptor
, calcitonin gene-related peptide type 1 receptor
, calcitonin receptor-like receptor